Literature DB >> 20965250

Nanostructured porous silicon microparticles enable sustained peptide (Melanotan II) delivery.

Miia Kilpeläinen1, Juha Mönkäre, Maria A Vlasova, Joakim Riikonen, Vesa-Pekka Lehto, Jarno Salonen, Kristiina Järvinen, Karl-Heinz Herzig.   

Abstract

Peptide molecules can improve the treatment of a number of pathological conditions, but due to their physicochemical properties, their delivery is very challenging. The study aim was to determine whether nanostructured porous silicon could sustain the release and prolong the duration of action of a model peptide Melanotan II (MTII). Thermally hydrocarbonized nanoporous silicon (THCPSi) microparticles (38-53 μm) were loaded with MTII. The pore diameter, volume, specific surface area and loading degree of the microparticles were analyzed, and the peptide release was evaluated in vitro. The effects of MTII on heart rate and water consumption were investigated in vivo after subcutaneous administration of the MTII loaded microparticles. A peptide loading degree of 15% w/w was obtained. In vitro studies (PBS, pH 7.4, 37 °C) indicated sustained release of MTII from the THCPSi microparticles. In vivo, MTII loaded THCPSi induced an increase in the heart rate 2 h later than MTII solution, and the effect lasted 1 h longer. In addition, MTII loaded THCPSi changed the water consumption after 150 min, when the immediate effect of MTII solution was already diminished. The present study demonstrates that MTII loading into nanosized PSi pore structure enables sustained delivery of an active peptide.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965250     DOI: 10.1016/j.ejpb.2010.10.004

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  8 in total

1.  Mesoporous silicon (PSi) for sustained peptide delivery: effect of psi microparticle surface chemistry on peptide YY3-36 release.

Authors:  Miia Kovalainen; Juha Mönkäre; Ermei Mäkilä; Jarno Salonen; Vesa-Pekka Lehto; Karl-Heinz Herzig; Kristiina Järvinen
Journal:  Pharm Res       Date:  2011-10-27       Impact factor: 4.200

2.  Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis.

Authors:  Tuulia Huhtala; Jussi Rytkönen; Anu Jalanko; Martti Kaasalainen; Jarno Salonen; Raili Riikonen; Ale Närvänen
Journal:  J Drug Deliv       Date:  2012-06-15

3.  In vitro dissolution methods for hydrophilic and hydrophobic porous silicon microparticles.

Authors:  Juha Mönkäre; Joakim Riikonen; Elina Rauma; Jarno Salonen; Vesa-Pekka Lehto; Kristiina Järvinen
Journal:  Pharmaceutics       Date:  2011-06-21       Impact factor: 6.321

4.  Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus.

Authors:  Iman K Yazdi; Matthew B Murphy; Christopher Loo; Xuewu Liu; Mauro Ferrari; Bradley K Weiner; Ennio Tasciotti
Journal:  J Tissue Eng       Date:  2014-05-19       Impact factor: 7.813

5.  Development of an oral push-pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles.

Authors:  Zongzhe Zhao; Chao Wu; Ying Zhao; Yanna Hao; Ying Liu; Wenming Zhao
Journal:  Int J Nanomedicine       Date:  2015-03-03

6.  Mesoporous Silicon Particles Favor the Induction of Long-Lived Humoral Responses in Mice to a Peptide-Based Vaccine.

Authors:  Gabriela Navarro-Tovar; Denisse Rocha-García; Alejandra Wong-Arce; Gabriela Palestino; Sergio Rosales-Mendoza
Journal:  Materials (Basel)       Date:  2018-06-26       Impact factor: 3.623

7.  Bone Morphogenic Protein 2-Loaded Porous Silicon Carriers for Osteoinductive Implants.

Authors:  Michal Rosenberg; Dekel Shilo; Leonid Galperin; Tal Capucha; Karim Tarabieh; Adi Rachmiel; Ester Segal
Journal:  Pharmaceutics       Date:  2019-11-12       Impact factor: 6.321

8.  Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors.

Authors:  Patrick V Almeida; Mohammad-Ali Shahbazi; Ermei Mäkilä; Martti Kaasalainen; Jarno Salonen; Jouni Hirvonen; Hélder A Santos
Journal:  Nanoscale       Date:  2014-09-07       Impact factor: 7.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.